CMA CGM Seine, a new 24,000 TEU LNG dual-fuel container ship classed by Bureau Veritas (BV) and built by Hudong-Zhonghua ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

Bureau Veritas Marine & Offshore (BV) announced the successful delivery of the CMA CGM SEINE, a new 24,000 TEU LNG dual-fuel ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

Following President Trump's tariff announcement, French President Emmanuel Macron said recent E.U. investments in the U.S. should be suspended until further notice.

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...

Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

The startup will develop bespoke AI models and agents to support a variety of use cases across CMA CGM’s business units.

The Simplera Sync™ is a disposable, all-in-one sensor that requires no fingersticks* with SmartGuard™ or overtape and features a simple, two-step insertion process. It is the company's newest addition ...

DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today the FDA has cleared the Dexcom G7 15 Day ...